Pneumococcal polysaccharide vaccine at 12 months of age produces functional immune responses

Journal of Allergy and Clinical Immunology

Volumn 129, Issue 3, 2012, Pages

  Licciardi, Paul V ^a   Balloch, Anne ^a   Russell, Fiona M ^a   Burton, Robert L ^b   Lin, Jisheng ^b   Nahm, Moon H ^b   Mulholland, Edward K ^c   Tang, Mimi L K ^a,d,e  

^a MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

23 valent pneumococcal polysaccharide vaccine (Pneumovax); antibody; avidity; function; opsonophagocytosis; Pneumococcal polysaccharide vaccine; Pneumovax; serotype

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; PNEUMOCOCCUS VACCINE;

ANTIBODY AFFINITY; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; BODY WEIGHT; DRUG SAFETY; ETHNICITY; FEMALE; FIJI; HUMAN; HUMAN TISSUE; IMMUNOGENICITY; IMMUNOGLOBULIN PRODUCTION; INFANT; MAJOR CLINICAL STUDY; MALE; OPSONIZATION; PHAGOCYTOSIS; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; SEROTYPE;

EID: 84862783591     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2011.11.043     Document Type: Article

References (40)

1. T. Wardlaw, E. Johansson, and M. Hodge Pneumonia: the forgotten killer of children 2006 UNICEF/WHO Geneva
2. I.H. Park, D.G. Pritchard, R. Cartee, A. Brandao, M.C. Brandileone, and M.H. Nahm Discovery of a new capsular serotype (6C) within serogroup 6 of Streptococcus pneumoniae J Clin Microbiol 45 2007 1225 1233 (Pubitemid 46626489)
3. H.L. Johnson, M. Deloria-Knoll, O.S. Levine, S.K. Stoszek, L. Freimanis Hance, and R. Reithinger Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project PLoS Med 2010 7
4. F.M. Russell, J.R. Carapetis, L. Tikoduadua, D. Paeds, R. Chandra, and A. Seduadua Invasive pneumococcal disease in Fiji: clinical syndromes, epidemiology, and the potential impact of pneumococcal conjugate vaccine Pediatr Infect Dis J 29 2010 870 872
5. N. Ekstrom, M. Vakevainen, J. Verho, T. Kilpi, and H. Kayhty Functional antibodies elicited by two heptavalent pneumococcal conjugate vaccines in the Finnish Otitis Media Vaccine Trial Infect Immun 75 2007 1794 1800 (Pubitemid 46559447)
6. M. Melin, H. Jarva, L. Siira, S. Meri, H. Kayhty, and M. Vakevainen Streptococcus pneumoniae capsular serotype 19F is more resistant to C3 deposition and less sensitive to opsonophagocytosis than serotype 6B Infect Immun 77 2009 676 684
7. M. Taillardet, G. Haffar, P. Mondiere, M.J. Asensio, T. Pleau-Pison, and N. Burdin Toll-like receptor agonists allow generation of long-lasting antipneumococcal humoral immunity in response to a plain polysaccharidic vaccine J Infect Dis 202 2010 470 479
8. A.J. Leach, P.S. Morris, G. Mackenzie, J. McDonnell, A. Balloch, and J. Carapetis Immunogenicity for 16 serotypes of a unique schedule of pneumococcal vaccines in a high-risk population Vaccine 26 2008 3885 3891
9. D. Goldblatt, J. Southern, L. Ashton, P. Richmond, P. Burbidge, and J. Tasevska Immunogenicity and boosting after a reduced number of doses of a pneumococcal conjugate vaccine in infants and toddlers Pediatr Infect Dis J 25 2006 312 319
10. F.M. Russell, P.V. Licciardi, A. Balloch, V. Biaukula, L. Tikoduadua, and J.R. Carapetis Safety and immunogenicity of the 23vPPV at 12 months of age, following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine in infancy Vaccine 28 2010 3086 3094
11. R.M. Douglas, J.C. Paton, S.J. Duncan, and D.J. Hansman Antibody response to pneumococcal vaccination in children younger than five years of age J Infect Dis 148 1983 131 137 (Pubitemid 13039322)
12. R.U. Sorensen, L.E. Leiva, F.C. Javier 3rd, D.M. Sacerdote, N. Bradford, and B. Butler Influence of age on the response to Streptococcus pneumoniae vaccine in patients with recurrent infections and normal immunoglobulin concentrations J Allergy Clin Immunol 102 1998 215 221 (Pubitemid 28406908)
13. K. Paris, and R.U. Sorensen Assessment and clinical interpretation of polysaccharide antibody responses Ann Allergy Asthma Immunol 99 2007 462 464 (Pubitemid 350086206)
14. N.D. Hare, B.J. Smith, and Z.K. Ballas Antibody response to pneumococcal vaccination as a function of preimmunization titer J Allergy Clin Immunol 123 2009 195 200
15. A. Balloch, P.V. Licciardi, F.M. Russell, E.K. Mulholland, and M.L. Tang Infants aged 12 months can mount adequate serotype-specific IgG responses to pneumococcal polysaccharide vaccine J Allergy Clin Immunol 126 2010 395 397
16. G.R. Siber, I. Chang, S. Baker, P. Fernsten, K.L. O'Brien, and M. Santosham Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies Vaccine 25 2007 3816 3826 (Pubitemid 46589754)
17. S.A. Plotkin Correlates of protection induced by vaccination Clin Vaccine Immunol 17 2010 1055 1065
18. D. Goldblatt, J. Southern, L. Ashton, N. Andrews, S. Woodgate, and P. Burbidge Immunogenicity of a reduced schedule of pneumococcal conjugate vaccine in healthy infants and correlates of protection for serotype 6B in the United Kingdom Pediatr Infect Dis J 29 2010 401 405
19. R.L. Burton, and M.H. Nahm Development and validation of a fourfold multiplexed opsonization assay (MOPA4) for pneumococcal antibodies Clin Vaccine Immunol 13 2006 1004 1009 (Pubitemid 44518968)
20. F.M. Russell, A. Balloch, M.L. Tang, J.R. Carapetis, P. Licciardi, and J. Nelson Immunogenicity following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine Vaccine 27 2009 5685 5691
21. F.M. Russell, A. Balloch, P.V. Licciardi, J.R. Carapetis, L. Tikoduadua, and L. Waqatakirewa Serotype-specific avidity is achieved following a single dose of the 7-valent pneumococcal conjugate vaccine, and is enhanced by 23-valent pneumococcal polysaccharide booster at 12 months Vaccine 29 2011 4499 4506
22. K.L. O'Brien, J. Moisi, S. Romero-Steiner, P. Holder, G.M. Carlone, and R. Reid Pneumococcal antibodies in a child with type 14 pneumococcal conjugate vaccine failure Vaccine 27 2009 1863 1868
23. A. Balloch, P.V. Licciardi, A. Leach, A. Nurkka, and M.L. Tang Results from an inter-laboratory comparison of pneumococcal serotype-specific IgG measurement and critical parameters that affect assay performance Vaccine 28 2010 1333 1340
24. M.A. Breukels, A. Zandvoort, G.T. Rijkers, M.E. Lodewijk, P.A. Klok, and G. Harms Complement dependency of splenic localization of pneumococcal polysaccharide and conjugate vaccines Scand J Immunol 61 2005 322 328 (Pubitemid 40637836)
25. H. Morbach, E.M. Eichhorn, J.G. Liese, and H.J. Girschick Reference values for B cell subpopulations from infancy to adulthood Clin Exp Immunol 162 2010 271 279
26. J.B. Carey, C.S. Moffatt-Blue, L.C. Watson, A.L. Gavin, and A.J. Feeney Repertoire-based selection into the marginal zone compartment during B cell development J Exp Med 205 2008 2043 2052
27. C. Laferriere The Immunogenicity of pneumococcal polysaccharides in infants and children: a meta-regression Vaccine 29 2011 6838 6847
28. H. Kayhty, H. Ahman, K. Eriksson, M. Sorberg, and L. Nilsson Immunogenicity and tolerability of a heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 12 months of age Pediatr Infect Dis J 24 2005 108 114 (Pubitemid 40250767)
29. S. Romero-Steiner, C.E. Frasch, G. Carlone, R.A. Fleck, D. Goldblatt, and M.H. Nahm Use of opsonophagocytosis for serological evaluation of pneumococcal vaccines Clin Vaccine Immunol 13 2006 165 169 (Pubitemid 43383782)
30. P.V. Licciardi, A. Balloch, F.M. Russell, M.H. Nahm, K. Mulholland, and M.L. Tang Pneumococcal glycoconjugate vaccines produce antibody responses that strongly correlate with function Nat Rev Drug Discov 10 2011 393
31. N. Ekstrom, H. Ahman, J. Verho, J. Jokinen, M. Vakevainen, and T. Kilpi Kinetics and avidity of antibodies evoked by heptavalent pneumococcal conjugate vaccines PncCRM and PncOMPC in the Finnish Otitis Media Vaccine Trial Infect Immun 73 2005 369 377 (Pubitemid 40041129)
32. P.V. Licciardi, A. Balloch, F.M. Russell, E.K. Mulholland, and M.L. Tang Antibodies to serotype 9V exhibit novel serogroup cross-reactivity following infant pneumococcal immunization Vaccine 28 2010 3793 3800
33. PneumoADIP. Pneumococcal Regional Serotype Distribution for Pneumococcal TPP. 2008; Available at: http://vaccineamc.org/files/TPP-Codebook.pdf: Accessed June 16, 2011.
34. K. Kolibab, S.L. Smithson, A.K. Shriner, S. Khuder, S. Romero-Steiner, and G.M. Carlone Immune response to pneumococcal polysaccharides 4 and 14 in elderly and young adults. I. Antibody concentrations, avidity and functional activity Immun Ageing 2 2005 10
35. I. Henckaerts, N. Durant, D. De Grave, L. Schuerman, and J. Poolman Validation of a routine opsonophagocytosis assay to predict invasive pneumococcal disease efficacy of conjugate vaccine in children Vaccine 25 2007 2518 2527 (Pubitemid 46366133)
36. Balloch A, Licciardi PV, Russell FM, Burton R, Nahm M, Mulholland K, et al. Does serotype-specific IgG and avidity to Streptococcus pneumoniae following infant immunisation correlate with functional opsonophagocytic activity? Presented at: 6th International Symposium on Pneumococci and Pneumococcal Diseases; 2008; Reykjavik, Iceland.
37. F.M. Russell, J.R. Carapetis, A. Balloch, P.V. Licciardi, A.W. Jenney, and L. Tikoduadua Hyporesponsiveness to re-challenge dose following pneumococcal polysaccharide vaccine at 12 months of age, a randomized controlled trial Vaccine 28 2010 3341 3349
38. F.M. Russell, J.R. Carapetis, R.L. Burton, J. Lin, P.V. Licciardi, and A. Balloch Opsonophagocytic activity following a reduced dose 7-valent pneumococcal conjugate vaccine infant primary series and 23-valent pneumococcal polysaccharide vaccine at 12 months of age Vaccine 29 2011 535 544
39. F.M. Russell, J.R. Carapetis, C. Satzke, L. Tikoduadua, L. Waqatakirewa, and R. Chandra Pneumococcal nasopharyngeal carriage following reduced doses of a 7-valent pneumococcal conjugate vaccine and a 23-valent pneumococcal polysaccharide vaccine booster Clin Vaccine Immunol 17 2010 1970 1976
40. K.A. O'Grady, K.J. Lee, J.B. Carlin, P.J. Torzillo, A.B. Chang, and E.K. Mulholland Increased risk of hospitalization for acute lower respiratory tract infection among Australian indigenous infants 5-23 months of age following pneumococcal vaccination: a cohort study Clin Infect Dis 50 2010 970 978